SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

SIGHINOLFI, LAURA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.434
EU - Europa 521
AS - Asia 156
AF - Africa 23
SA - Sud America 12
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 2.151
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.419
IT - Italia 167
FR - Francia 144
VN - Vietnam 79
PL - Polonia 50
CN - Cina 40
DE - Germania 32
GB - Regno Unito 23
SE - Svezia 22
RU - Federazione Russa 16
CA - Canada 15
FI - Finlandia 15
IN - India 13
CZ - Repubblica Ceca 12
ZA - Sudafrica 11
UA - Ucraina 10
AE - Emirati Arabi Uniti 8
BR - Brasile 7
ET - Etiopia 6
IE - Irlanda 5
JP - Giappone 5
NL - Olanda 5
CL - Cile 4
DK - Danimarca 4
ID - Indonesia 4
AU - Australia 3
BE - Belgio 3
BG - Bulgaria 3
LT - Lituania 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CH - Svizzera 2
HK - Hong Kong 2
AL - Albania 1
AT - Austria 1
BJ - Benin 1
BT - Bhutan 1
CM - Camerun 1
ES - Italia 1
HU - Ungheria 1
IL - Israele 1
KR - Corea 1
NG - Nigeria 1
PE - Perù 1
PT - Portogallo 1
TH - Thailandia 1
TR - Turchia 1
TZ - Tanzania 1
UG - Uganda 1
ZW - Zimbabwe 1
Totale 2.151
Salva come PNG Salva come JPEG
Città #
Santa Cruz 246
Fairfield 106
Ashburn 92
Dong Ket 78
Seattle 74
Woodbridge 63
Des Moines 56
Houston 54
Warsaw 50
Buffalo 40
Chicago 33
Columbus 33
Castello Di Fiemme 32
Ferrara 32
Cambridge 30
Wilmington 27
Ann Arbor 23
Paris 21
San Diego 21
Stockholm 20
Santa Maria Di Sala 17
Los Angeles 15
New York 15
Helsinki 11
Las Vegas 11
Shanghai 11
Dallas 10
Rome 10
Henderson 7
Milan 7
Saint Petersburg 7
San Jose 7
Bengaluru 6
Guangzhou 6
Dublin 5
Grenoble 5
Lake Forest 5
Muizenberg 5
Providence 5
Provo 5
Beijing 4
Boardman 4
Boulder 4
Clearwater 4
Pune 4
Rosolina 4
Saskatoon 4
Scranton 4
Toronto 4
Addis Ababa 3
Council Bluffs 3
Crugers 3
Durban 3
Herndon 3
Lappeenranta 3
Lyngby 3
Montreal 3
Recife 3
Reston 3
Shenzhen 3
Sofia 3
Adelaide 2
Atlanta 2
Auburn 2
Cedar Knolls 2
Chandler 2
Chennai 2
Denver 2
Dulles 2
Frankfurt am Main 2
Hamburg 2
Hefei 2
Hong Kong 2
Irpin 2
Jacksonville 2
Lincoln 2
Lombard 2
Manchester 2
Miami 2
Mountain View 2
Mullica Hill 2
Nantes 2
Naples 2
Negrar 2
Omaha 2
Palermo 2
Portland 2
Riva 2
Salt Lake City 2
San Francisco 2
San Mateo 2
Saronno 2
Tappahannock 2
Valeggio sul Mincio 2
Yellow Springs 2
Aalst 1
Abano Terme 1
Amsterdam 1
Andover 1
Antwerp 1
Totale 1.446
Salva come PNG Salva come JPEG
Nome #
Drop in CD4+ Counts Below 200 Cells/μL After Reaching (or Starting From) Values Higher than 350 Cells/μL in HIV-Infected Patients With Virological Suppression, file e309ade2-cc68-3969-e053-3a05fe0a2c94 144
Cytomegalovirus coinfection is associated with an increased risk of severe non-AIDS-defining events in a large cohort of HIV-infected patients, file e309ade2-c8f2-3969-e053-3a05fe0a2c94 99
Triglyceride/HDL ratio and its impact on the risk of diabetes mellitus development during ART, file e309ade2-c8f7-3969-e053-3a05fe0a2c94 96
Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline VIRO-immunological status and outcome in patients under first-line ART, file e309ade2-d399-3969-e053-3a05fe0a2c94 95
Short-term weight gain after antiretroviral therapy initiation and subsequent risk of cardiovascular disease and diabetes: The D: A: D study, file e309ade2-d3a6-3969-e053-3a05fe0a2c94 90
Active HCV Replication but Not HCV or CMV Seropositive Status Is Associated with Incident and Prevalent Type 2 Diabetes in Persons Living with HIV, file e309ade2-cb76-3969-e053-3a05fe0a2c94 87
Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Naïve for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004–2014, file e309ade2-d217-3969-e053-3a05fe0a2c94 77
Increased risk of virologic failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: Data from the ICONA cohort, file e309ade2-d046-3969-e053-3a05fe0a2c94 75
HIV-1 co-receptor tropism and liver fibrosis in HIV-infected patients, file e309ade2-c530-3969-e053-3a05fe0a2c94 74
Incidence and risk factors for liver enzyme elevation among naive HIV-1-infected patients receiving ART in the ICONA cohort, file e309ade2-d360-3969-e053-3a05fe0a2c94 73
Refining criteria for selecting candidates for a safe lopinavir/ritonavir or darunavir/ritonavir monotherapy in HIV-infected virologically suppressed patients, file e309ade2-c6af-3969-e053-3a05fe0a2c94 66
Discontinuation of initial antiretroviral therapy in clinical practice: Moving toward individualized therapy, file e309ade2-c879-3969-e053-3a05fe0a2c94 64
Inflammatory effects of atazanavir/ritonavir versus darunavir/ritonavir in treatment naïve, HIV-1-infected patients, file e309ade2-c109-3969-e053-3a05fe0a2c94 62
Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study, file e309ade2-ca75-3969-e053-3a05fe0a2c94 62
Incidence and factors associated with the risk of sexually transmitted diseases in HIV-infected people seen for care in Italy: Data from the Icona Foundation cohort, file e309ade2-d39b-3969-e053-3a05fe0a2c94 61
Long-term durability of tenofovir-based antiretroviral therapy In relation to the Co-administration of other drug classes in routine clinical practice, file e309ade2-d556-3969-e053-3a05fe0a2c94 60
Access and response to direct antiviral agents (DAA) in HIV-HCV co-infected patients in Italy: data from the Icona cohort, file e309ade2-c5f3-3969-e053-3a05fe0a2c94 59
Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: An observational cohort study, file e309ade2-d39a-3969-e053-3a05fe0a2c94 59
Effectiveness of dolutegravir-based regimens as either first-line or switch antiretroviral therapy: data from the Icona cohort, file e309ade2-cb06-3969-e053-3a05fe0a2c94 58
Gender differences in the use of cardiovascular interventions in HIV-positive persons; the D:A:D study, file e309ade2-d3cb-3969-e053-3a05fe0a2c94 58
Evaluation of the prognostic value of impaired renal function on clinical progression in a large cohort of HIV-infected people seen for care in Italy, file e309ade2-cd76-3969-e053-3a05fe0a2c94 57
Response to first-line ritonavir-boosted protease inhibitors (PI/r)-based regimens in HIV positive patients presenting to care with low CD4 counts: Data from the Icona Foundation Cohort, file e309ade2-d3d4-3969-e053-3a05fe0a2c94 57
Incidence and progression to cirrhosis of new hepatitis C virus infections in persons living with human immunodeficiency virus, file e309ade2-d555-3969-e053-3a05fe0a2c94 57
Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for people living with HIV in Italy, file e309ade2-d032-3969-e053-3a05fe0a2c94 56
Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection?, file e309ade2-cbd4-3969-e053-3a05fe0a2c94 54
Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus, file e309ade2-c8f6-3969-e053-3a05fe0a2c94 53
Impact of diabetes on the risk of serious liver events and liver-related deaths in people living with HIV and hepatitis C co-infection: data from the ICONA Foundation Cohort Study, file e309ade2-dde1-3969-e053-3a05fe0a2c94 47
A Comparison Between Different Anti-Retroviral Therapy Regimes on Soluble Inflammation Markers: a Pilot Study, file e309ade2-c2b5-3969-e053-3a05fe0a2c94 45
Evaluation of HIV Transmission Clusters among Natives and Foreigners Living in Italy, file e309ade4-d546-3969-e053-3a05fe0a2c94 41
Adipokines levels in HIV infected patients: lipocalin-2 and fatty acid binding protein-4 as possible markers of HIV and antiretroviral therapy-related adipose tissue inflammation, file e309ade1-b2b9-3969-e053-3a05fe0a2c94 39
First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison, file e309ade2-cc69-3969-e053-3a05fe0a2c94 33
The impact of DAA-mediated HCV eradication on CD4+ and CD8+ T lymphocyte trajectories in HIV/HCV coinfected patients: Data from the ICONA Foundation Cohort, file c6ffdf39-4b54-4a65-a968-37961066a163 26
Virological response and retention in care according to time of starting ART in Italy: data from the Icona Foundation Study cohort, file e309ade4-85e5-3969-e053-3a05fe0a2c94 21
Durability of different initial regimens in HIV-infected patients starting antiretroviral therapy with CD4+ counts <200 cells/mm3 and HIV-RNA >5 log10 copies/mL, file e309ade2-cb0e-3969-e053-3a05fe0a2c94 20
Very high pre-therapy viral load is a predictor of virological rebound in HIV-1-infected patients starting a modern first-line regimen, file e309ade2-dddf-3969-e053-3a05fe0a2c94 20
COVID-19 in eastern Emilia: an unusual epidemiology in Northern Italy, file e309ade2-bd27-3969-e053-3a05fe0a2c94 16
null, file e309ade2-c65b-3969-e053-3a05fe0a2c94 15
Active HCV Replication but Not HCV or CMV Seropositive Status Is Associated with Incident and Prevalent Type 2 Diabetes in Persons Living with HIV, file e309ade2-dea4-3969-e053-3a05fe0a2c94 13
Real-life use of elbasvir/grazoprevir in adults and elderly patients: a prospective evaluation of comedications used in the PITER cohort, file e309ade4-9662-3969-e053-3a05fe0a2c94 10
Human immunodeficiency virus continuum of care in 11 european union countries at the end of 2016 overall and by key population: Have we made progress?, file 73c00d70-a72c-41d2-8988-3535910bf388 7
Impact of diabetes on the risk of serious liver events and liver-related deaths in people living with HIV and hepatitis C co-infection: data from the ICONA Foundation Cohort Study, file e309ade2-c5ff-3969-e053-3a05fe0a2c94 2
Durability and tolerability of first-line regimens including two nucleoside reverse transcriptase inhibitors and raltegravir or ritonavir boosted-atazanavir or -darunavir: data from the ICONA Cohort *, file e309ade2-c6d3-3969-e053-3a05fe0a2c94 2
Very high pre-therapy viral load is a predictor of virological rebound in HIV-1-infected patients starting a modern first-line regimen, file e309ade2-c6d8-3969-e053-3a05fe0a2c94 2
First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison, file e309ade2-cc6a-3969-e053-3a05fe0a2c94 2
The impact of DAA-mediated HCV eradication on CD4+ and CD8+ T lymphocyte trajectories in HIV/HCV coinfected patients: Data from the ICONA Foundation Cohort, file 38c5ec04-d04f-4e3b-92d3-4ab6dc1eccdd 1
Virological response and retention in care according to time of starting ART in Italy: data from the Icona Foundation Study cohort, file e309ade4-93ca-3969-e053-3a05fe0a2c94 1
Inflammatory effects of atazanavir/ritonavir versus darunavir/ritonavir in treatment naïve, HIV-1-infected patients, file e309ade4-e80c-3969-e053-3a05fe0a2c94 1
Totale 2.217
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.769
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.769
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021512 0 0 0 27 124 55 35 45 29 57 24 116
2021/2022711 33 25 19 22 55 38 55 59 46 46 236 77
2022/2023590 15 31 187 99 27 54 49 56 19 12 25 16
2023/2024403 9 15 41 11 52 73 18 53 63 27 41 0
Totale 2.217